Lipoprotein(a) and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors
Clinical Research in Cardiology Supplements - Germany
doi 10.1007/s11789-019-00099-z
Full Text
Open PDFAbstract
Available in full text
Date
March 5, 2019
Authors
Publisher
Springer Science and Business Media LLC